Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “pCR Rate”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Very early researchUnknownNCT04130750
What this trial is testing

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

Who this might be right for
Breast CancerNeoadjuvant ChemotherapyDrug Effect
Peking University People's Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06925243
What this trial is testing

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 682
Testing effectiveness (Phase 2)Looking for participantsNCT06276868
What this trial is testing

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 71
Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11
Testing effectiveness (Phase 2)Ended earlyNCT01929811
What this trial is testing

NeoMET Study in Neoadjuvant Treatment of Breast Cancer

Who this might be right for
pCR RateBCT RateSafety
Shanghai Jiao Tong University School of Medicine 92
Not applicableStudy completedNCT01958229
What this trial is testing

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BRoadmap Concept in Chronic Hepatitis B Treatment24-week PCR Negativity of Telbivudine+2 more
National Taiwan University Hospital 23
Not applicableStudy completedNCT01903889
What this trial is testing

Male Engagement in PMTCT Services

Who this might be right for
HIV
FHI 360 3,806
Not applicableWithdrawnNCT04878042
What this trial is testing

COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray

Who this might be right for
COVID-19
EPISTATA
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090031
What this trial is testing

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Who this might be right for
EFSpCR Rate
Qingdao Central Hospital 49
Testing effectiveness (Phase 2)Study completedNCT02543255
What this trial is testing

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Who this might be right for
Prostate Cancer
University Health Network, Toronto 76
Not applicableStudy completedNCT05673850
What this trial is testing

Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy

Who this might be right for
Breast Neoplasms
Peking University 518
Not applicableUnknownNCT02975115
What this trial is testing

Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization

Who this might be right for
Chronic Myelocytic Leukemia
Seoul St. Mary's Hospital 102
Testing effectiveness (Phase 2)Looking for participantsNCT04677816
What this trial is testing

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Who this might be right for
Triple Negative Breast CancerVitamin D DeficiencyInvasive Breast Cancer
Wake Forest University Health Sciences 50
Not applicableLooking for participantsNCT07430579
What this trial is testing

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Who this might be right for
Pathological Complete RemissionObjective Response RateImmune-related Adverse Events+1 more
The Second Hospital of Shandong University 25
Testing effectiveness (Phase 2)UnknownNCT04340401
What this trial is testing

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 25
Testing effectiveness (Phase 2)Looking for participantsNCT06596018
What this trial is testing

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Who this might be right for
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 96
Not applicableStudy completedNCT04108910
What this trial is testing

Morbidity Rate for UTI Through Use of PCR-Based Diagnosis and Management

Who this might be right for
Urinary Tract Infections
Pathnostics 66,381
Testing effectiveness (Phase 2)UnknownNCT03650738
What this trial is testing

This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment

Who this might be right for
Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Large-scale testing (Phase 3)Looking for participantsNCT06949033
What this trial is testing

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 668
Load More Results